Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Maxxim Medical/Sterile Concepts

This article was originally published in The Gray Sheet

Executive Summary

Maxxim Medical/Sterile Concepts: Maxxim ups bid for Sterile Concepts to approximately $135 mil. "in cash or newly issued shares of Maxxim common stock or a combination of the two," the firm states in a March 25 release. Under the terms of the revised proposal, Maxxim would pay $19 per share for all outstanding shares of Sterile Concepts and would assume about $29 mil. in Sterile Concepts debt. The offer expires on April 1. Sterile Concepts has retained Wheat First Butcher Singer to help it "explore its strategic alternatives, including a possible combination" with Maxxim. Sterile Concepts has rejected two previous offers from Maxxim. The first offer was valued at $118 mil.; the second offer, valued at $128 mil., was rejected March 14...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel